West Chester, OH, United States of America

Ashraf Traboulsi

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ashraf Traboulsi

Introduction

Ashraf Traboulsi is a notable inventor based in West Chester, OH (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing innovative oral dosage forms that enhance the delivery of active ingredients.

Latest Patents

Among his latest patents, Traboulsi has developed a rheological solid oral composition. This composition includes a crystallizing agent, an aqueous phase, and an oral active agent. Another notable patent is for a quick dissolving diphenhydramine oral dosage form. This formulation is designed to deliver diphenhydramine through the sublingual or buccal mucosa. It contains diphenhydramine or a pharmaceutically acceptable salt, a permeability enhancer, and a buffering agent. The buffering agent is capable of achieving a pH of about 7.0 to about 8.0, and the diphenhydramine can completely dissolve within approximately 2 minutes.

Career Highlights

Traboulsi is currently employed at The Procter & Gamble Company, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug delivery systems, making medications more effective and user-friendly.

Collaborations

Traboulsi has collaborated with several talented individuals in his field, including Richard John Dansereau and Brian Laster. These collaborations have fostered a creative environment that encourages the development of groundbreaking solutions.

Conclusion

Ashraf Traboulsi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in creating effective oral dosage forms. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…